Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Investment in Macrophage Therapeutics, Inc. (Details Textual)

v3.20.1
Note 6 - Investment in Macrophage Therapeutics, Inc. (Details Textual)
1 Months Ended
Mar. 31, 2015
shares
Macrophage Therapeutics [Member]  
Convertible Preferred Stock Shares Issued Upon Conversion, Per Unit (in shares) 1